Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MEDAHUB appears to be a healthcare technology company rather than a drug developer. Publicly available sources describe it as a cannabis-related healthcare technology business offering HIPAA-compliant technology and licensing solutions spanning workflows from seed-to-sale and doctor-to-patient, and associated with a Florida compounding pharmacy license. The entity appears to have operated through MEDAHUB, Inc. and MEDAHUB Operations Group, Inc. In 2018, Acacia Diversified Holdings announced that it had acquired both entities through its subsidiaries. Available evidence suggests MEDAHUB was commercializing software and operational infrastructure in regulated healthcare and medical cannabis settings, not advancing a conventional therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MEDAHUB Companies.